Alfano, F.; Gori, A.M.; Berteotti, M.; Rogolino, A.; Cesari, F.; Salvadori, E.; Formelli, B.; Pescini, F.; Barbato, C.; Giusti, B.;
et al. Pleiotropic Effects of Oral Anticoagulant Therapy: Is There a Difference Between VKAs and DOACs? Biomedicines 2025, 13, 1850.
https://doi.org/10.3390/biomedicines13081850
AMA Style
Alfano F, Gori AM, Berteotti M, Rogolino A, Cesari F, Salvadori E, Formelli B, Pescini F, Barbato C, Giusti B,
et al. Pleiotropic Effects of Oral Anticoagulant Therapy: Is There a Difference Between VKAs and DOACs? Biomedicines. 2025; 13(8):1850.
https://doi.org/10.3390/biomedicines13081850
Chicago/Turabian Style
Alfano, Francesco, Anna Maria Gori, Martina Berteotti, Angela Rogolino, Francesca Cesari, Emilia Salvadori, Benedetta Formelli, Francesca Pescini, Carmen Barbato, Betti Giusti,
and et al. 2025. "Pleiotropic Effects of Oral Anticoagulant Therapy: Is There a Difference Between VKAs and DOACs?" Biomedicines 13, no. 8: 1850.
https://doi.org/10.3390/biomedicines13081850
APA Style
Alfano, F., Gori, A. M., Berteotti, M., Rogolino, A., Cesari, F., Salvadori, E., Formelli, B., Pescini, F., Barbato, C., Giusti, B., Poggesi, A., & Marcucci, R.
(2025). Pleiotropic Effects of Oral Anticoagulant Therapy: Is There a Difference Between VKAs and DOACs? Biomedicines, 13(8), 1850.
https://doi.org/10.3390/biomedicines13081850